These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 15475458

  • 1. Characterization of the hollow fiber assay for the determination of microtubule disruption in vivo.
    Suggitt M, Swaine DJ, Pettit GR, Bibby MC.
    Clin Cancer Res; 2004 Oct 01; 10(19):6677-85. PubMed ID: 15475458
    [Abstract] [Full Text] [Related]

  • 2. The hollow fiber assay: continued characterization with novel approaches.
    Hall LA, Krauthauser CM, Wexler RS, Hollingshead MG, Slee AM, Kerr JS.
    Anticancer Res; 2000 Oct 01; 20(2A):903-11. PubMed ID: 10810375
    [Abstract] [Full Text] [Related]

  • 3. Pseudolaric acid B, a novel microtubule-destabilizing agent that circumvents multidrug resistance phenotype and exhibits antitumor activity in vivo.
    Wong VK, Chiu P, Chung SS, Chow LM, Zhao YZ, Yang BB, Ko BC.
    Clin Cancer Res; 2005 Aug 15; 11(16):6002-11. PubMed ID: 16115945
    [Abstract] [Full Text] [Related]

  • 4. A novel oral indoline-sulfonamide agent, N-[1-(4-methoxybenzenesulfonyl)-2,3-dihydro-1H-indol-7-yl]-isonicotinamide (J30), exhibits potent activity against human cancer cells in vitro and in vivo through the disruption of microtubule.
    Liou JP, Hsu KS, Kuo CC, Chang CY, Chang JY.
    J Pharmacol Exp Ther; 2007 Oct 15; 323(1):398-405. PubMed ID: 17660383
    [Abstract] [Full Text] [Related]

  • 5. The hollow fibre model--facilitating anti-cancer pre-clinical pharmacodynamics and improving animal welfare.
    Suggitt M, Cooper PA, Shnyder SD, Bibby MC.
    Int J Oncol; 2006 Dec 15; 29(6):1493-9. PubMed ID: 17088988
    [Abstract] [Full Text] [Related]

  • 6. [Effects of CPUY013, a novel Topo I inhibitor, on human gastric adenocarcinoma BGC823 cells in vitro and in vivo].
    Ji YB, Zhou JH, Zuo MX, You QD.
    Yao Xue Xue Bao; 2008 Aug 15; 43(8):811-8. PubMed ID: 18956773
    [Abstract] [Full Text] [Related]

  • 7. Cytotoxic activity and cytostatic mechanism of novel 2-arylbenzo[b]furans.
    Yang H, Pang JY, Cai YC, Xu ZL, Xian LJ.
    J Pharm Pharmacol; 2006 Sep 15; 58(9):1281-7. PubMed ID: 16945188
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Laulimalide and isolaulimalide, new paclitaxel-like microtubule-stabilizing agents.
    Mooberry SL, Tien G, Hernandez AH, Plubrukarn A, Davidson BS.
    Cancer Res; 1999 Feb 01; 59(3):653-60. PubMed ID: 9973214
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Vitamin K3 disrupts the microtubule networks by binding to tubulin: a novel mechanism of its antiproliferative activity.
    Acharya BR, Choudhury D, Das A, Chakrabarti G.
    Biochemistry; 2009 Jul 28; 48(29):6963-74. PubMed ID: 19527023
    [Abstract] [Full Text] [Related]

  • 14. Earthworm fibrinolytic enzyme: anti-tumor activity on human hepatoma cells in vitro and in vivo.
    Chen H, Takahashi S, Imamura M, Okutani E, Zhang ZG, Chayama K, Chen BA.
    Chin Med J (Engl); 2007 May 20; 120(10):898-904. PubMed ID: 17543180
    [Abstract] [Full Text] [Related]

  • 15. Quinoline derivative KB3-1 potentiates paclitaxel induced cytotoxicity and cycle arrest via multidrug resistance reversal in MES-SA/DX5 cancer cells.
    Koo JS, Choi WC, Rhee YH, Lee HJ, Lee EO, Ahn KS, Bae HS, Ahn KS, Kang JM, Choi SU, Kim MO, Lu J, Kim SH.
    Life Sci; 2008 Nov 21; 83(21-22):700-8. PubMed ID: 18845169
    [Abstract] [Full Text] [Related]

  • 16. In vitro and in vivo studies of a novel potential anticancer agent of isochaihulactone on human lung cancer A549 cells.
    Chen YL, Lin SZ, Chang JY, Cheng YL, Tsai NM, Chen SP, Chang WL, Harn HJ.
    Biochem Pharmacol; 2006 Jul 28; 72(3):308-19. PubMed ID: 16782069
    [Abstract] [Full Text] [Related]

  • 17. Zoledronic acid is unable to induce apoptosis, but slows tumor growth and prolongs survival for non-small-cell lung cancers.
    Li YY, Chang JW, Chou WC, Liaw CC, Wang HM, Huang JS, Wang CH, Yeh KY.
    Lung Cancer; 2008 Feb 28; 59(2):180-91. PubMed ID: 17900752
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Identification and characterization of A-105972, an antineoplastic agent.
    Wu-Wong JR, Alder JD, Alder L, Burns DJ, Han EK, Credo B, Tahir SK, Dayton BD, Ewing PJ, Chiou WJ.
    Cancer Res; 2001 Feb 15; 61(4):1486-92. PubMed ID: 11245455
    [Abstract] [Full Text] [Related]

  • 20. [Effects of beta-sitosterol on microtubular systems in cervical cancer cells].
    Wang L, Yang YJ, Chen SH, Ge XR, Xu CJ, Gui SQ.
    Zhonghua Yi Xue Za Zhi; 2006 Oct 24; 86(39):2771-5. PubMed ID: 17199997
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.